Characterization of COPD admissions during the first COVID-19 outbreak
|Autor/es||Cosío, Borja G.
López-Campos Bodineau, José Luis
Soler-Cataluña, Juan José
|Departamento||Universidad de Sevilla. Departamento de Medicina|
|Resumen||Purpose: Exacerbations of COPD (ECOPD) are a frequent cause of hospitalization that seemed to ameliorate during the COVID outbreak. We aimed to evaluate the clinical characteristics of COPD-related hospital admissions and ...
Purpose: Exacerbations of COPD (ECOPD) are a frequent cause of hospitalization that seemed to ameliorate during the COVID outbreak. We aimed to evaluate the clinical characteristics of COPD-related hospital admissions and mortality in relation to the presence of COVID-19. Patients and Methods: We conducted a case-control study of patients admitted in four teaching hospitals throughout Spain between March 15 and April 30, 2020. Hospital admis- sions of respiratory cause with and without PCR-proven SARS-CoV-2 infection in patients with COPD were evaluated. Baseline and episode-related clinical characteristics were ana- lyzed. Logistic regression analysis was performed to evaluate the risk for mortality. Results: During the study period, 2101 patients were admitted for respiratory worsening, 1200 (57.1%) with COVID-19. A total of 228 (10.8%) were admitted due to COPD worsening, of whom 52 (22.8%) tested positive for COVID-19. COPD patients with COVID-19, when compared to those without COVID-19, were more frequently males with better lung function (FEV1 postbronchodilator 71% vs 46% respectively, p<0.001) and had higher mortality (44.9% vs 13.6% respectively, p<0.001) despite similar age, comorbidities, total days of hospitalization and admission to intensive care unit. COVID-19 and eosinopenia were the strongest risk factors for mortality in the multivariate analysis in the overall COPD population. Inhaled corticosteroid use was not associated to mortality. Conclusion: Hospitalizations for ECOPD without COVID-19 were more frequent than COPD with COVID-19 during the first outbreak, but the latter were associated with higher mortality and low eosinophil counts that warrant further analysis. © 2021 Cosio et al.
|Agencias financiadoras||GlaxoSmithKline (GSK)|
|Cita||Cosío, B.G., Shafiek, H., Toledo-Pons, N., Iglesias, A., Barceló, M., Represas-Represas, C. y López-Campos Bodineau, J.L. (2021). Characterization of COPD admissions during the first COVID-19 outbreak. International Journal of Chronic Obstructive Pulmonary Disease, 16, 1549-1554. https://doi.org/10.2147/COPD.S312493.|